CME Group (CME) Panoramica del titolo
CME Group Inc. gestisce, insieme alle sue controllate, mercati contrattuali per la negoziazione di futures e opzioni su contratti futures in tutto il mondo. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 0/6 |
| Prestazioni passate | 4/6 |
| Salute finanziaria | 5/6 |
| Dividendi | 4/6 |
CME Community Fair Values
Create NarrativeSee what 97 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di CME Group Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$274.98 |
| Massimo di 52 settimane | US$329.16 |
| Minimo di 52 settimane | US$218.31 |
| Beta | 0.27 |
| Variazione di 1 mese | 7.70% |
| Variazione a 3 mesi | -2.68% |
| Variazione di 1 anno | 1.32% |
| Variazione a 3 anni | 35.24% |
| Variazione a 5 anni | 37.98% |
| Variazione dall'IPO | 3,104.90% |
Notizie e aggiornamenti recenti
Recent updates
Seeking Alpha • Aug 13
CME Group: 'Buy' The Market's Infrastructure
Summary CME Group operates as the world's leading derivatives marketplace, serving as essential infrastructure for stock and fixed income markets. CME benefits from interest rate volatility, proprietary benchmark products, and a high-margin, recurring revenue model with 33 consecutive quarters of market data growth. Shares trade at a forward P/E of 21.8, a 9% discount to a $290 fair value estimate; consensus expects 7.5% annual EPS growth through 2028. Risks include periods of market calm compressing volumes and potential competition from OTC platforms, but CME's dominant position and dividend growth remain compelling. Read the full article on Seeking Alpha
Aggiornamento narrativa • Jul 28
CME: Perpetual Futures Dispute And New Contracts Will Shape Earnings Profile
The analyst fair value estimate for CME Group has been trimmed by about $6.64 to $282.36, as analysts balance slightly higher projected revenue growth with lower profit margin assumptions and a modestly reduced future P/E multiple following a mix of recent target cuts and increases across the Street. Analyst Commentary Recent research on CME Group shows a split view, with some firms lifting price targets and ratings while others trim expectations and flag competitive threats.Aggiornamento narrativa • Jul 09
CME: Crypto Perpetual Futures Dispute Will Reshape Long Term Earnings Power
The analyst price target for CME Group has been trimmed by about $14 to reflect slightly softer revenue growth assumptions, a modestly higher discount rate, and lower future P/E multiples that many analysts link to competitive concerns around perpetual futures, despite broadly constructive views on the core franchise. Analyst Commentary Recent research on CME Group highlights a split view, with some analysts seeing attractive upside after the share pullback and others focusing on competitive threats and pricing pressure.Aggiornamento narrativa • Jun 24
CME: Crypto Perpetual Futures Dispute Will Shape Future Earnings Power
The analyst price target for CME Group has shifted slightly lower, with fair value moving from about $306.47 to $302.60 as analysts weigh ongoing concerns around perpetual futures and potential multiple compression against views that recent share weakness and structural demand drivers still support an attractive long term setup. Analyst Commentary Recent research on CME Group shows a split between bullish analysts who see the recent pullback and product portfolio as supportive for long term value, and more cautious voices focused on competitive threats from perpetual futures and the potential impact on valuation multiples.Articolo di analisi • Jun 18
CME Group (CME) Stock Could Be 18% Undervalued After CEO Succession News
CME Group (CME) stock is in focus after the company confirmed a leadership transition that will see long time Chairman and CEO Terry Duffy move to Executive Chairman while President and CFO Lynne Fitzpatrick becomes CEO in 2027. See our latest analysis for CME Group. The leadership announcement landed against a weaker backdrop for CME Group stock, with the share price down 3.46% over the past day and 17.23% over the past 30 days, while the 5 year total shareholder return of 45.07% still...Aggiornamento narrativa • Jun 05
CME: Crypto And AI Futures Expansion Will Shape Future Earnings Power
Analysts have trimmed their average price target for CME Group to about $306.47. This reflects concerns that revenue momentum could soften as geopolitical volatility eases and that fresh competition in bitcoin perpetual futures may weigh on exchange valuations, even as several firms still see the competitive risk as manageable.Aggiornamento narrativa • May 15
CME: Mixed Street Views And New Markets Will Shape Future Earnings Power
Narrative Update on CME Group The analyst price target for CME Group has been trimmed by about $2, reflecting updated views on slightly softer revenue growth and a modestly lower future P/E multiple. At the same time, some analysts highlight areas of support such as commodities volumes as well as agriculture and prediction markets.Aggiornamento narrativa • Apr 27
CME: Volatile Street Views And New Futures Will Shape Trading Mix
Analysts have nudged their fair value estimate for CME Group down to $308.20 from $311.67, reflecting slightly softer revenue growth assumptions and a higher discount rate, partly balanced by a higher projected profit margin and a modestly lower future P/E, in line with the mix of recent price target trims and increases across the Street. Analyst Commentary Recent Street research on CME Group has been active on both sides, with several firms adjusting price targets and ratings in different directions.Aggiornamento narrativa • Apr 11
CME: Volatility And New Contracts Will Shape Rare Earths And Crypto Volumes
The updated analyst price target for CME Group has moved higher by about $5 to $311.67. This change reflects analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a marginally higher future P/E multiple, even as they factor in a small trim to projected profit margins.Aggiornamento narrativa • Mar 26
CME: Volatility And New Contracts Will Shape Rare Earths And Volume Mix
Analysts have made a modest upward adjustment to the CME Group fair value estimate to about $307 from roughly $305, reflecting slightly revised assumptions for discount rate, revenue growth, profit margin, and future P/E following a mix of recent rating changes and price target tweaks across the Street. Analyst Commentary Recent research on CME Group reflects a mixed but generally balanced backdrop, with several firms adjusting ratings and price targets in different directions.Aggiornamento narrativa • Mar 11
CME: Volatility And New Contracts Will Shape Rare Earths And Clearing Outlook
Our analyst price target for CME Group has moved modestly higher to $305.21 from $299.29, as analysts factor in slightly stronger modeled revenue growth and profitability. This is partially offset by a more conservative future P/E assumption and mixed views on volume drivers across product lines.Aggiornamento narrativa • Feb 25
CME: Volatility And New Contracts Will Shape Futures And Clearing Outlook
The analyst price target for CME Group edges higher to $232, with recent updates reflecting analysts' focus on firmer commodities volumes, as well as a more expense conscious outlook in their refreshed earnings models. Analyst Commentary Recent Street research around CME Group reflects a mix of optimism on volumes and earnings power, alongside caution on valuation and the cost base.Aggiornamento narrativa • Feb 10
CME: Volatility And Prediction Markets Will Guide Futures And Clearing Expansion Outlook
The updated analyst price target for CME Group edges higher to about US$297 from roughly US$290, reflecting analysts' use of a slightly lower discount rate, a modestly higher assumed revenue growth rate, and a similar future P/E multiple despite a slightly lower profit margin input. Analyst Commentary Street research on CME Group in recent sessions centers on a cluster of revised price targets and at least one rating change, with several bullish analysts lifting their targets by varying dollar amounts and one major bank fine tuning its view in both directions over a short time frame.Aggiornamento narrativa • Jan 27
CME: Volatility And Prediction Markets Will Shape Futures Activity Outlook
The analyst price target for CME Group is now US$290.40, a move of about US$2 from the prior US$288.33, as analysts factor in slightly different assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following mixed recent research that includes both a modest target cut and an upgrade linked to a tilt toward volatility. Analyst Commentary Recent research on CME Group reflects a mix of optimism and caution, with one firm trimming its price target slightly and another upgrading the stock on what it sees as a better setup for volatility related trading activity.Aggiornamento narrativa • Jan 12
CME: Fee Moat And Prediction Markets Will Shape Futures Activity Outlook
Narrative Update: CME Group CME Group's fair value estimate has edged up by about $1 to roughly $288 per share, as analysts cite the company's strong futures and options moat, a higher price target range of up to $314, and interest in its role within prediction markets as key supports for the updated outlook. Analyst Commentary Recent Street research has been generally constructive on CME Group, with several bullish analysts adjusting their price targets higher and highlighting the company's futures and options franchise as a key support for valuation.Aggiornamento narrativa • Dec 27
CME: Fee Resilience And Prediction Markets Will Balance Lower Volatility Risks
Analysts have nudged their average price target on CME Group modestly higher, to approximately $287 from about $286, citing the company’s resilient fee-based revenue mix, strong competitive moat in futures and options, and supportive demand signals from prediction market partnerships despite some conflicting views on near term volume volatility. Analyst Commentary Recent Street research presents a mixed but generally constructive view on CME Group, with upward moves in price targets tempered by concerns around volume sensitivity and valuation risk if volatility normalizes.Aggiornamento narrativa • Dec 13
CME: Fee Resilience And New Prediction Markets Will Help Navigate Volatility
Analysts have raised their fair value estimate for CME Group by about $1 to roughly $286 per share, citing the company’s resilient clearing and transaction fee driven revenue base, modestly higher long term growth expectations, and a reinforced competitive moat highlighted in recent target revisions across the Street. Analyst Commentary Street research on CME Group reflects a wide range of views on valuation and execution, with recent target changes clustering around expectations for resilient fee income but diverging on the sustainability of growth and the impact of lower volatility.Aggiornamento narrativa • Nov 16
CME: Revenue Resilience And New Ventures Will Balance Volatility Risks Ahead
The average analyst price target for CME Group was raised by approximately $3 to $285, as analysts point to the firm's resilient revenue streams and strong market position amid continued macroeconomic uncertainty. Analyst Commentary Recent analyst activity reflects a mix of optimism and caution regarding CME Group's performance and outlook, particularly as the firm navigates shifting macroeconomic and market conditions.Rendimenti per gli azionisti
| CME | US Capital Markets | US Mercato | |
|---|---|---|---|
| 7D | 2.7% | 1.2% | -1.2% |
| 1Y | 1.3% | 6.0% | 18.3% |
Ritorno vs Industria: CME ha avuto una performance inferiore rispetto al US Capital Markets che ha registrato un rendimento 6 % nell'ultimo anno.
Rendimento vs Mercato: CME ha avuto una performance inferiore al mercato US che ha registrato un rendimento 18.3 % nell'ultimo anno.
Volatilità dei prezzi
| CME volatility | |
|---|---|
| CME Average Weekly Movement | 4.5% |
| Capital Markets Industry Average Movement | 3.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Prezzo delle azioni stabile: CME non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 5% ) di CME è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1898 | 3,875 | Terry Duffy | www.cmegroup.com |
CME Group Inc., insieme alle sue controllate, gestisce mercati contrattuali per la negoziazione di futures e opzioni su contratti futures in tutto il mondo. Offre prodotti futures e opzioni basati su tassi di interesse, indici azionari e valute estere, nonché su materie prime agricole, energetiche e metallurgiche, oltre a servizi di negoziazione di titoli a reddito fisso e valute estere. La società fornisce servizi di stanza di compensazione, tra cui la compensazione, il regolamento e la garanzia dei contratti a termine e delle opzioni, nonché dei prodotti swap compensati negoziati attraverso le proprie borse.
CME Group Inc. Riepilogo dei fondamenti
| CME statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$98.88b |
| Utili (TTM) | US$4.27b |
| Ricavi(TTM) | US$6.76b |
23.2x
Rapporto P/E14.6x
Rapporto P/SCME è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| CME Conto economico (TTM) | |
|---|---|
| Ricavi | US$6.76b |
| Costo del fatturato | US$0 |
| Profitto lordo | US$6.76b |
| Altre spese | US$2.49b |
| Utili | US$4.27b |
Ultimi utili riportati
Jun 30, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 11.86 |
| Margine lordo | 100.00% |
| Margine di profitto netto | 63.12% |
| Rapporto debito/patrimonio netto | 12.9% |
Come si è comportato CME nel lungo periodo?
Vedi performance storica e confrontoDividendi
4.1%
Rendimento attuale del dividendo43%
Rapporto di remunerazioneCME paga dividendi affidabili?
Vedere la storia dei dividendi e i benchmark di CME| CME Group date dei dividendi | |
|---|---|
| Data di stacco del dividendo | Sep 09 2026 |
| Data di pagamento dei dividendi | Sep 25 2026 |
| Giorni fino al dividendo Ex | 16 days |
| Giorni prima della data di pagamento dei dividendi | 32 days |
CME paga dividendi affidabili?
Vedere la storia dei dividendi e i benchmark di CMEAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/08/24 03:57 |
| Prezzo dell'azione a fine giornata | 2026/08/21 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
CME Group Inc. è coperta da 32 analisti. 13 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Stephen Biggar | Argus Research Company |
| Benjamin Budish | Barclays |
| Roger Freeman | Barclays |